Lv3
380 积分 2026-02-04 加入
Phase 1 study of oncolytic virus VV1 as monotherapy or in combination with avelumab in patients with relapsed refractory solid tumors
5天前
已关闭
LRRC15-CAR T cells for the treatment of osteosarcoma
6个月前
已完结
Measuring T-cell/CAR T-cell bystander tumor killing in vitro and in vivo
6个月前
已完结
Optimizing In Vivo CAR-T Cell Engineering for Cancer Immunotherapy
6个月前
已完结
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies
6个月前
已完结
The dawn of in vivo immune cell engineering in oncology
6个月前
已完结
Dual-target CAR-T therapy for ovarian cancer: synergistic targeting of MSLN and B7H3 enhances anti-tumor efficacy and overcomes antigen heterogeneity
6个月前
已完结
Single-Chain IL-23 Secretion by CAR T Cells Improves Tumor Control and Persistence Against Solid Tumors
6个月前
已完结
Clinical Trial Results Provide the Rationale to Protect Dual HIV-specific T Cells with a Signaling-Defective HIV Fusion Inhibitor
6个月前
已完结
Enhancing Adoptive T Cell Therapy by Disrupting the SKI-SMAD2/3 Axis to Counteract TGF-β-Mediated Immunosuppression
6个月前
已关闭
皖公网安备34019202002308
